TY  - RPRT
TI  - Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes.
AU  - Ozden Altundag
AU  - Kadri Altundag
AU  - Paolo Morandi
AU  - Mehmet Gunduz
PY  - 2004
DO  - 10.1016/j.mehy.2004.03.013
UR  - https://pubmed.ncbi.nlm.nih.gov/15236790/
ID  - 15236790
ER  -